Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 54

1.

Lessons learned from a paying antiretroviral therapy service in the public health sector at Kamuzu Central Hospital, Malawi: 1-year experience.

Hosseinipour MC, Neuhann FH, Kanyama CC, Namarika DC, Weigel R, Miller W, Phiri SJ.

J Int Assoc Physicians AIDS Care (Chic). 2006 Sep;5(3):103-8.

PMID:
16928878
2.

The lessons learned from paying antiretroviral therapy in Malawi.

Muula AS.

J Int Assoc Physicians AIDS Care (Chic). 2007 Jun;6(2):94. No abstract available.

PMID:
17537999
4.

Incidence and predictors of death, retention, and switch to second-line regimens in antiretroviral- treated patients in sub-Saharan African Sites with comprehensive monitoring availability.

Palombi L, Marazzi MC, Guidotti G, Germano P, Buonomo E, Scarcella P, Doro Altan A, Zimba Ida V, San Lio MM, De Luca A; DREAM Program..

Clin Infect Dis. 2009 Jan 1;48(1):115-122.

PMID:
20380075
5.

Evaluation of antiretroviral therapy results in a resource-poor setting in Blantyre, Malawi.

van Oosterhout JJ, Bodasing N, Kumwenda JJ, Nyirenda C, Mallewa J, Cleary PR, de Baar MP, Schuurman R, Burger DM, Zijlstra EE.

Trop Med Int Health. 2005 May;10(5):464-70.

6.

Dropout and re-enrollment: implications for epidemiological projections of treatment programs.

Klein DJ, Bershteyn A, Eckhoff PA.

AIDS. 2014 Jan;28 Suppl 1:S47-59. doi: 10.1097/QAD.0000000000000081.

PMID:
24468946
7.

A national survey of teachers on antiretroviral therapy in Malawi: access, retention in therapy and survival.

Makombe SD, Jahn A, Tweya H, Chuka S, Yu JK, Hochgesang M, Aberle-Grasse J, Thambo L, Schouten EJ, Kamoto K, Harries AD.

PLoS One. 2007 Jul 18;2(7):e620.

8.

Attrition among human immunodeficiency virus (HIV)- infected patients initiating antiretroviral therapy in China, 2003-2010.

Zhu H, Napravnik S, Eron J, Cole S, Ma Y, Wohl D, Dou Z, Zhang Y, Liu Z, Zhao D, Cohen M, Zhang F.

PLoS One. 2012;7(6):e39414. doi: 10.1371/journal.pone.0039414. Epub 2012 Jun 27.

9.

Gender differences in retention and survival on antiretroviral therapy of HIV-1 infected adults in Malawi.

Taylor-Smith K, Tweya H, Harries A, Schoutene E, Jahn A.

Malawi Med J. 2010 Jun;22(2):49-56.

10.

Healthcare utilization of patients accessing an African national treatment program.

Harling G, Orrell C, Wood R.

BMC Health Serv Res. 2007 Jun 7;7:80.

11.

The benefit of supplementary feeding for wasted Malawian adults initiating ART.

van Oosterhout JJ, Ndekha M, Moore E, Kumwenda JJ, Zijlstra EE, Manary M.

AIDS Care. 2010 Jun;22(6):737-42. doi: 10.1080/09540120903373581.

PMID:
20467944
12.

Predictors for mortality and loss to follow-up among children receiving anti-retroviral therapy in Lilongwe, Malawi.

Fetzer BC, Hosseinipour MC, Kamthuzi P, Hyde L, Bramson B, Jobarteh K, Torjesen K, Miller WC, Hoffman I, Kazembe P, Mwansambo C.

Trop Med Int Health. 2009 Aug;14(8):862-9. doi: 10.1111/j.1365-3156.2009.02315.x. Epub 2009 Jun 28.

13.

A national survey of prisoners on antiretroviral therapy in Malawi: access to treatment and outcomes on therapy.

Makombe SD, Jahn A, Tweya H, Thambo L, Yu JK, Hedt B, Weigel R, Nkhata A, Schouten EJ, Kamoto K, Harries AD.

J Infect Dev Ctries. 2007 Dec 1;1(3):303-7.

14.

Unacceptable attrition among WHO stages 1 and 2 patients in a hospital-based setting in rural Malawi: can we retain such patients within the general health system?

Tayler-Smith K, Zachariah R, Massaquoi M, Manzi M, Pasulani O, van den Akker T, Bemelmans M, Bauernfeind A, Mwagomba B, Harries AD.

Trans R Soc Trop Med Hyg. 2010 May;104(5):313-9. doi: 10.1016/j.trstmh.2010.01.007. Epub 2010 Feb 6.

PMID:
20138323
15.

Malawi's contribution to "3 by 5": achievements and challenges.

Libamba E, Makombe SD, Harries AD, Schouten EJ, Yu JK, Pasulani O, Mhango E, Aberle-Grasse J, Hochgesang M, Limbambala E, Lungu D.

Bull World Health Organ. 2007 Feb;85(2):156-60.

16.

A national survey of prisoners on antiretroviral therapy in Malawi: access to treatment and outcomes on therapy.

Makombe SD, Jahn A, Tweya H, Thambo L, Yu JK, Hedt B, Weigel R, Nkhata A, Schouten EJ, Kamoto K, Harries AD.

World Hosp Health Serv. 2008;44(1):26-9.

PMID:
18549031
17.

Outcomes of patients with Kaposi's sarcoma who start antiretroviral therapy under routine programme conditions in Malawi.

Makombe SD, Harries AD, Yu JK, Hochgesang M, Mhango E, Weigel R, Pasulani O, Fitzgerald M, Schouten EJ, Libamba E.

Trop Doct. 2008 Jan;38(1):5-7. doi: 10.1258/td.2007.060023.

PMID:
18302849
18.

Causes of death and risk factors for mortality among HIV-infected patients receiving antiretroviral therapy in Korea.

Lee SH, Kim KH, Lee SG, Cho H, Chen DH, Chung JS, Kwak IS, Cho GJ.

J Korean Med Sci. 2013 Jul;28(7):990-7. doi: 10.3346/jkms.2013.28.7.990. Epub 2013 Jul 3.

19.

Scaling up of highly active antiretroviral therapy in a rural district of Malawi: an effectiveness assessment.

Ferradini L, Jeannin A, Pinoges L, Izopet J, Odhiambo D, Mankhambo L, Karungi G, Szumilin E, Balandine S, Fedida G, Carrieri MP, Spire B, Ford N, Tassie JM, Guerin PJ, Brasher C.

Lancet. 2006 Apr 22;367(9519):1335-42.

PMID:
16631912
20.

Pharmacokinetic comparison of generic and trade formulations of lamivudine, stavudine and nevirapine in HIV-infected Malawian adults.

Hosseinipour MC, Corbett AH, Kanyama C, Mshali I, Phakati S, Rezk NL, van der Horst C, Kashuba AD.

AIDS. 2007 Jan 2;21(1):59-64.

PMID:
17148968

Supplemental Content

Support Center